Macrogenics (MGNX) Provides Update on Corporate Progress, TAMARACK Phase 2 Study Data, Q1 Results
Go back to Macrogenics (MGNX) Provides Update on Corporate Progress, TAMARACK Phase 2 Study Data, Q1 Results| MACROGENICS (NASDAQ: MGNX) | Delayed: 4.14 +0.01 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.13 | 52 Week High | $36.11 | |||
| Open | $4.12 | 52 Week Low | $14.84 | |||
| Day High | $4.17 | P/E | 10.62 | |||
| Day Low | $4.09 | EPS | $0.39 | |||
| Volume | 873,939 | |||||

